Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage

被引：0
|
作者：
Mark R.Kelley
Jill C.Fehrenbacher
机构：
[1] Pediatric Oncology Research
[2] Departments of Biochemistry & Molecular Biology and Pharmacology & Toxicology
[3] HB Wells Center for Pediatric Research
[4] Basic Science Research,Indiana University Simon Cancer Center
[5] Department of Pharmacology and Toxicology
[6] Stark Neuroscience Research Institute
[7] Department of Anesthesiology,Indiana University School of Medicine
来源：
Neural Regeneration Research | 2017年 / 12卷 / 01期
基金：
美国国家卫生研究院;
关键词：
CIPN; DNA; Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage;
D O I：
暂无
中图分类号：
R745 [周围神经及神经节疾病];
学科分类号：
摘要：
Background on chemotherapy-induced peripheral neuropathy(CIPN)Incidence,prevalence,and consequences:Up to 90%of cancer patients experience CIPN at some point during or after anticancer treatment(Seretny et al.,2014).Although CIPN is second to hematologic toxicities in regards to the frequency of incidence,
引用
收藏
页码：72 / 74
页数：3
相关论文
共 50 条
  • [41] Chemotherapy-induced peripheral neuropathy: From symptomatology using quantitative sensory testing towards effective treatment
    Marynissen, Heleen
    Mergaerts, Delphine
    Wildiers, Hans
    Neven, Patrick
    Van Cutsem, Eric
    De Hoon, Jan
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [42] The effects of sensorimotor training and whole body vibration on patients suffering from chemotherapy-induced peripheral neuropathy
    Streckmann, F.
    Lehmann, H. C.
    Heller, A.
    Schuerhoerster, A.
    Grossek, A.
    Bloch, W.
    Baumann, F. T.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 154 - 154
  • [43] Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients' Profiles With Oxaliplatin-Induced Peripheral Neuropathy
    Kerckhove, Nicolas
    Selvy, Marie
    Lambert, Celine
    Gonneau, Coralie
    Feydel, Gabrielle
    Petorin, Caroline
    Vimal-Baguet, Agnes
    Melnikov, Sergey
    Kullab, Sharif
    Hebbar, Mohamed
    Bouche, Olivier
    Slimano, Florian
    Bourgeois, Vincent
    Lebrun-Ly, Valerie
    Thuillier, Frederic
    Mazard, Thibault
    Tavan, David
    Benmammar, Kheir Eddine
    Monange, Brigitte
    Ramdani, Mohamed
    Pere-Verge, Denis
    Huet-Penz, Floriane
    Bedjaoui, Ahmed
    Genty, Florent
    Leyronnas, Cecile
    Busserolles, Jerome
    Trevis, Sophie
    Pinon, Vincent
    Pezet, Denis
    Balayssac, David
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [44] Assessment of chemotherapy-induced DNA damage in peripheral blood leukocytes of cancer patients using the alkaline comet assay
    Kopjar, N
    Garaj-Vrhovac, V
    Milas, I
    TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS, 2002, 22 (01): : 13 - 30
  • [45] Therapeutic benefits of maintaining mitochondrial integrity and calcium homeostasis by forced expression of Hsp27 in chemotherapy-induced peripheral neuropathy
    Chine, Virendra Bhagawan
    Au, Ngan Pan Bennett
    Ma, Chi Him Eddie
    NEUROBIOLOGY OF DISEASE, 2019, 130
  • [46] From Chemotherapy-Induced Emesis to Neuroprotection: Therapeutic Opportunities for 5-HT3 Receptor Antagonists
    Gohar Fakhfouri
    Kazem Mousavizadeh
    Sharam Ejtemaei Mehr
    Ahmad Reza Dehpour
    Mohammad Reza Zirak
    Jean-Eric Ghia
    Reza Rahimian
    Molecular Neurobiology, 2015, 52 : 1670 - 1679
  • [47] From Chemotherapy-Induced Emesis to Neuroprotection: Therapeutic Opportunities for 5-HT3 Receptor Antagonists
    Fakhfouri, Gohar
    Mousavizadeh, Kazem
    Mehr, Sharam Ejtemaei
    Dehpour, Ahmad Reza
    Zirak, Mohammad Reza
    Ghia, Jean-Eric
    Rahimian, Reza
    MOLECULAR NEUROBIOLOGY, 2015, 52 (03) : 1670 - 1679
  • [48] Prevention of Chemotherapy-Induced Peripheral Neuropathy With PRESIONA, a Therapeutic Exercise and Blood Flow Restriction Program: A Randomized Controlled Study Protocol
    Lopez-Garzon, Maria
    Cantarero-Villanueva, Irene
    Legeren-Alvarez, Marta
    Gallart-Aragon, Tania
    Postigo-Martin, Paula
    Gonzalez-Santos, Angela
    Lozano-Lozano, Mario
    Martin-Martin, Lydia
    Ortiz-Comino, Lucia
    Castro-Martin, Eduardo
    Ariza-Garcia, Angelica
    Fernandez-Lao, Carolina
    Arroyo-Morales, Manuel
    Galiano-Castillo, Noelia
    PHYSICAL THERAPY, 2022, 102 (03):
  • [49] Identifying patient characteristics associated with chemotherapy-induced peripheral neuropathy (CIPN) severity in a phase II clinical trial: A retrospective analysis.
    Zhi, Wanqing Iris
    Dreyfus, Nechama
    Dooley, Andee
    Piulson, Lauren
    Li, Qing Susan
    Bao, Ting
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: Taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGF
    Kirchmair, Rudolf
    Tietz, Anne B.
    Panagiotou, Eleftheria
    Walter, Dirk H.
    Silver, Marcy
    Yoon, Young-Sup
    Schratzberger, Peter
    Weber, Alberto
    Kusano, Kengo
    Weinberg, David H.
    Ropper, Allan H.
    Isner, Jeffrey M.
    Losordo, Douglas W.
    MOLECULAR THERAPY, 2007, 15 (01) : 69 - 75
12345